![Marco Peters](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marco Peters is currently the Vice President & Head-Translation Science at Longboard Pharmaceuticals, Inc. Previously, he worked as the Senior Director-Research & Development at Biointervene, Inc. from 2020 to 2021.
Dr. Peters holds a doctorate degree from the University of London and a graduate degree from Freie Universität Berlin.
| Empresas | Cargo | Inicio |
|---|---|---|
| LONGBOARD PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
Biointervene, Inc.
 Biointervene, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Director Técnico/Científico/I+D | 01/03/2021 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 4 |
|---|---|
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Freie Universität Berlin
 Freie Universität Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biointervene, Inc.
Biointervene, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Longboard Pharmaceuticals, Inc.
 Longboard Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for neurological diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
